| | The BioHealth Capital Region Maintains Top 3 Spot in GEN’s 2025 U.S. Biopharma Cluster Rankings | For the third consecutive year, the BioHealth Capital Region (BHCR), encompassing Maryland, Virginia, and Washington, D.C., has earned a Top 3 position in the highly regarded “Top 10 U.S. Biopharma Clusters” list by Genetic Engineering & Biotechnology News (GEN). | | BioHealth Innovation, Inc. Welcomes Two New Members to Its Board of Directors, Amy Adams of GMU and Dr. Jessica Nadler of Deloitte | BioHealth Innovation, Inc. (BHI), a leading public-private nonprofit organization dedicated to advancing healthcare innovation in the BioHealth Capital Region, is pleased to announce the appointment of two new members to its Board of Directors: Amy Adams, Executive Director of the Institute for Biohealth Innovation at George Mason University, and Dr. Jessica Nadler, Managing Director at Deloitte. | |  | Deka Biosciences Publishes New Data in Cell Reports Medicine, Announces Search for Combination Partners for DK210(EGFR) | |
Germantown, MD — Deka Biosciences, a clinical-stage biotechnology company developing next-generation cytokine therapies for cancer and inflammatory disease, announced the publication of a peer-reviewed manuscript in Cell Reports Medicine highlighting the unique mechanism of action behind its lead Diakine™ oncology asset, DK210 (EGFR).
| | | 3 Days, 1 Region, Endless Opportunities: What to Expect at BHCR Week 2025 | Planning is well underway for BioHealth Capital Region Week 2025, and hundreds of attendees have already registered for the Forum taking place September 23–25 at US Pharmacopeia in Rockville, Maryland. Now in its 11th year, this free, three-day event brings together the people shaping the future of biohealth, including industry leaders, entrepreneurs, investors, government officials, and academic researchers, for insight, collaboration, and deal-making. | | | MaxCyte Announces Strategic Platform Licensing Agreement with Anocca AB to Advance TCR-T Cell Therapy Pipeline | ROCKVILLE, Md., July 31, 2025 (GLOBE NEWSWIRE) — MaxCyte, Inc., (Nasdaq: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of .... | | | Connect Capital and Innovation at the BioHealth Capital Region Investment Conference on September 25, 2025 at US Pharmacopeia, Rockville, MD | The Annual BioHealth Capital Region Investment Conference is the premier destination for discovering emerging companies that are redefining what’s possible in life sciences. Taking… | | | Win Over $45,000 in Prizes at the 2025 BHCR Crab Trap Pitch Competition | Applications are now being accepted for the Annual Crab Trap competition on September 24, 2025 during the BioHealth Capital Region Forum, spotlighting groundbreaking early-stage companies in therapeutics, diagnostics, medical devices, and more. Finalists will pitch live in front of investors and industry leaders during BioHealth Capital Region Week. | | | Supernus Pharmaceuticals Completes Acquisition of Sage Therapeutics | |
ROCKVILLE, Md., July 31, 2025 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN) (“Supernus”) today announced that it has successfully completed its previously announced acquisition of Sage Therapeutics, Inc.
| | |
At Johns Hopkins, University Research Powers Biotech—But Federal Cuts Loom
| Johns Hopkins University biomedical engineer Jean Fan and her team develop—and freely share—computational tools that give researchers everywhere the ability to discover breakthrough cancer drugs... | | | | | |
